Back to search

Article

GLP-1R agonists activate human hypothalamic neurons

2024-04-03

Abstract excerpt

Drugs like semaglutide (a.k.a. Ozempic/Wegovy) that activate the glucagon-like peptide-1 receptor (GLP-1R) are a promising therapy for obesity and type 2 diabetes (T2D). Animal studies suggest that these drugs likely function by stimulating GLP-1R on appetite-suppressing neuron populations in the brain, but it is still unclear how they act to reduce food intake in humans. We therefore generated appetite-regulatory...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
696013f7-5521-5f0c-9868-57c7e009b640
DOI
10.1101/2024.04.02.587825
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GLP-1R agonists activate human hypothalamic neuronsDOI 10.1101/2024.04.02.587825
Select a neighboring publication to make it the new centre.